INTERNATIONAL PATENT: PRINCIPIA BIOPHARMA INC. FILES APPLICATION FOR "TREATMENT OF CHRONIC SPONTANEOUS URTICARIA BY ADMINISTERING (R)-2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4- D]PYRIMIDIN-L-YL]PIPERIDINE-L-CARBONYL]-4-METHYL-4-[4-(OXETAN-3- YL)PIPERAZIN-L-YL]PENT-2-ENENITRILE"

GENEVA, May 6 -- PRINCIPIA BIOPHARMA INC. (55 Corporate DriveBridgewater, New Jersey 08807) filed a patent application (PCT/US2024/052717) for "TREATMENT OF CHRONIC SPONTANEOUS URTICARIA BY ADMINISTERING (R)-2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4- D]PYRIMIDIN-L-YL]PIPERIDINE-L-CARBONYL]-4-METHYL-4-[4-(OXETAN-3- YL)PIPERAZIN-L-YL]PENT-2-ENENITRILE" on Oct 24, 2024. With publication no. WO/2025/090703, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GEREIGE, Jessica (c/o Sanofi, Patent Department450 Water S...